Matsui M, Kuroda Y
Department of Internal Medicine, Saga Medical School.
Nihon Rinsho. 1994 Nov;52(11):2873-9.
The biological phenomenon that experimental animals become hyporesponsive to a particular protein antigen, when orally administered, is called oral tolerance. A breakdown of oral tolerance to dietary antigens may be related to food allergy. Conversely, the induction of oral tolerance by feeding autoantigens, such as myelin basic protein, protects animals from subsequent immunization by this antigen resulting in development of experimental autoimmune encephalomyelitis, which is a disease model of the human demyelinating disease, multiple sclerosis (MS). The mechanism of oral tolerance could be an induction of suppressor cells, which release inhibitory cytokines including transforming growth factor beta, when triggered antigen-specifically and/or clonal anergy to fed antigen. Against this background, patients with MS and rheumatoid arthritis are on a clinical trial with bovine myelin and type II collagen feeding, respectively. Oral tolerance could be a part of the mainstream in future treatment strategies for human diseases with autoimmune etiologies.
实验动物经口服给予特定蛋白质抗原后出现反应性降低的生物学现象称为口服耐受。对饮食抗原的口服耐受破坏可能与食物过敏有关。相反,通过喂食自身抗原(如髓鞘碱性蛋白)诱导口服耐受,可保护动物免受该抗原随后的免疫接种,从而预防实验性自身免疫性脑脊髓炎的发生,该疾病是人类脱髓鞘疾病多发性硬化症(MS)的疾病模型。口服耐受的机制可能是诱导抑制性细胞,当被抗原特异性触发和/或对喂食抗原产生克隆无能时,这些细胞会释放包括转化生长因子β在内的抑制性细胞因子。在此背景下,MS患者和类风湿性关节炎患者分别正在进行牛髓鞘和II型胶原蛋白喂食的临床试验。口服耐受可能会成为未来自身免疫性病因人类疾病治疗策略主流的一部分。